Liposome-encapsulated Daunorubicin-Cytarabine, Fludarabine Phosphate, Cytarabine, and Filgrastim in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Cytarabine
Related studies linked through entity extraction aliases.
Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy
- Status
- UNKNOWN
- Phase
- PHASE2
Ibrutinib, Idarubicin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) With an IDH1 and/or IDH2 Mutation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Pilot Study of Crenolanib Combined With Standard Salvage Chemotherapy in Subjects With R/R AML
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Donor Cellular Therapy After Cytarabine in Treating Patients With Intermediate-Risk Acute Myeloid Leukemia in Remission
- Status
- WITHDRAWN
- Phase
- PHASE2
Biomarkers in Predicting Treatment Response to Sirolimus and Chemotherapy in Patients With High-Risk Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
MLN 9708 in Induction and Consolidation for Adults With AML >= 60 Years of Age
- Status
- COMPLETED
- Phase
- PHASE1
Selinexor With Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Trial of Alisertib With Induction Chemotherapy in High-risk AML
- Status
- COMPLETED
- Phase
- PHASE2
Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Idasanutlin With Cytarabine Versus Cytarabine Plus Placebo in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
- Status
- TERMINATED
- Phase
- PHASE3
A Phase Ib Study of Belinostat With RDHAP Chemotherapy (Dexamethasone, Cytarabine, Cisplatinum) in Adults With Relapsed or Refractory Diffuse Large B-cell Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Pacritinib Combined With Decitabine or Cytarabine in Older Patients With AML
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Volasertib Plus Induction Chemotherapy for Acute Myeloid Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE1
Dasatinib Combined With Chemotherapy in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Alvocidib Biomarker-driven Phase 2 AML Study
- Status
- TERMINATED
- Phase
- PHASE2
Combination Chemotherapy and Donor Stem Cell Transplant Followed by Ixazomib Citrate Maintenance Therapy in Treating Patients With Relapsed High-Risk Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
BL-8040 Addition to Consolidation Therapy in AML Patients
- Status
- UNKNOWN
- Phase
- PHASE2